HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial

P.M. Ridker, J. Genest, S.M. Boekholdt, P. Libby, A.M. Gotto, B.G. Nordestgaard, S. Mora, J.G. MacFadyen, R.J. Glynn, J.J.P. Kastelein

    185 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences